Leading Pharmaceutical Operational Excellence: Outstanding Practices and Cases - Hardcover

9783642351600: Leading Pharmaceutical Operational Excellence: Outstanding Practices and Cases
Alle Exemplare der Ausgabe mit dieser ISBN anzeigen:
 
 
Reseña del editor:
Achieving operational excellence is a challenge for the pharmaceutical industry, with many companies setting successful examples time and again. This book presents such leading practices for managing operational excellence throughout the pharmaceutical industry. Based on the St.Gallen OPEX Model the authors describe the current status of OPEX and the future challenges that have to be dealt with. The ample theoretical background is complemented hand-in-hand by case studies contributed by authors from leading pharmaceutical companies.
Biografía del autor:

Thomas Friedli

 

Thomas Friedli is Managing Director at the Chair of Production Management, and Vice Director, Institute of Technology Management, University of St.Gallen (Switzerland). Thomas Friedli’s main research focus is the management of manufacturing enterprises. His area of expertise is in operational excellence in the pharmaceutical industry, collaboration management, management of industrial services and management of global production.

In 2004, Thomas habilitated and became Adjunct Professor in St.Gallen. His team of 12 postgraduate students develops new management solutions for manufacturing companies. The Chair is largely financed through external funds, while most of the research projects are industrial projects. In 2007 he became an associate member to the International Academy for Quality (IAQ) and joined the SAQ (Swiss Association for Quality and Management Systems) as an advisory council in 2009. Since 2010, he is member of the board of the Swiss Institute of Service Sciences (SISS).

Thomas is teaching in several executive programs in St.Gallen, Fribourg, Dornbirn, Salzburg and Aachen; moreover, he is visiting lecturer at the Business School of Bordeaux. In fall 2008, he spent several weeks as Adjunct Associate Professor at the Purdue University in West Lafayette, Indiana, USA. Since 2011, Thomas is Senior Lecturer of the Executive MBA program in St.Gallen and since 2012 also Senior Lecturer of the St.Gallen full time MBA program.

Prabir Basu

Prabir Basu is an independent consultant advising on pharmaceutical manufacturing and cGMP issues. From 2005 till June, 2013, Prabir was the Executive Director of the National Institute for Pharmaceutical Technology and Education (NIPTE) which is currently a non-profit organization supported by 13 leading universities in the U.S. NIPTE’s goal is to address long-term fundamental research and education on the science of pharmaceutical development and manufacturing. As the Executive Director of NIPTE, Prabir built a strong relationship with the U.S. FDA and secured funding from the FDA for research and education programs to modernize drug manufacturing. Working with the U.S. FDA, Prabir was also able to secure a U01 Grant for NIPTE in 2011 worth up to $35 million over 5 years to improve drug manufacturing standards.

From 2004 to 2010, along with his role as Executive Director, NITPE, Prabir was also the Managing Director of the Pharmaceutical Technology Education Center at Purdue University’s Discovery Park. In this role, Prabir, along with colleagues at Purdue and scientists from the industry, organized and offered various training courses on cGMP, Pharmaceutical Development and Manufacturing.

Prabir, along with his colleagues at Purdue University also founded NIPTE at Purdue in 2005. Prior to joining Purdue University, Prabir worked in the pharmaceutical industry (Pfizer, Pharmacia and Searle) for over 20 years in various capacities in research, development and manufacturing. During that period, Prabir had broad-ranging global senior management responsibilities for product development, manufacturing and outsourcing.

Daniel Bellm


Daniel Bellm is Research Associate at the chair of production management of the University of St.Gallen and as group coordinator responsible for the topic “Operational Excellence – Pharma”. His research focus is the management of operational excellence programs and complexity management. He is currently working on his PhD-thesis.

Daniel graduated in Business Engineering (Dipl.-Wi.-Ing.) at the Karlsruhe Institute of Technology (former University of Karlsruhe (TH), Germany). During his studies, Daniel worked at the Porsche AG (Germany), MTU Friedrichshafen (Germany), Porsche Asia Pacific Pte. Ltd. (Singapore), and Volkswagen Consulting (Germany).

Jürgen Werani


Jürgen Werani was born in Vienna, Austria, in 1951. He is a citizen of Switzerland. From 1971 until 1976, he studied pharmacy at the University of Graz, Austria. He received his doctorate in natural sciences in 1978. In 1998, he obtained a degree in Business Administration at the University of St.Gallen. In 2008, he received his Lean Expert qualification from the Lean Management Institute Germany. Between 1979 and 1995, Dr. Werani held a number of leading positions in pharmaceutical manufacturing at Sandoz Pharma AG in Basel, Switzerland. There he finally took on the role of Head of Solids Production. In 1995, he transferred to Warner Lambert Company where he became Managing Director of the Gödecke AG Freiburg plant. In 1998, he joined Gödecke AG’s Board of Management. From 2000 onwards, he was member of the Board of Management of Pfizer Germany GmbH. From 2003 to 2008, Dr. Werani was responsible for the implementation of the Operational Excellence Program in Europe which included its deployment to a total of 15 sites. Since 2008, he has been member of the Managing Board of Schuh & Co. Complexity Management AG in St.Gallen,
Switzerland.

Dr. Jürgen Werani has gained broad experience in the field of Operational Excellence and Lean Thinking in the pharmaceutical industry as well as in state-of-the-art methods of corporate management and leadership. He is the author and co-author of reference books on these subjects, wrote numerous publications and is a sought-after speaker at congresses and seminars on corporate change management. During his time at Pfizer Freiburg, Dr. Werani introduced the principles of Lean
Manufacturing on a broad scale, thus helping to turn the site into a leading Lean Manufacturing production site in the pharmaceutical industry. Since 2008 he has been leading several projects in different companies addressing Operational Excellence, Cultural Change and Leadership Development programs. He also acts as a mentor and coach for Executives and operational
leaders.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

Weitere beliebte Ausgaben desselben Titels

9783662510964: Leading Pharmaceutical Operational Excellence: Outstanding Practices and Cases

Vorgestellte Ausgabe

ISBN 10:  3662510960 ISBN 13:  9783662510964
Verlag: Springer, 2016
Softcover

  • 9783642351624: Leading Pharmaceutical Operational Excellence: Outstanding Practices and Cases

    Springer, 2013
    Softcover

Beste Suchergebnisse bei AbeBooks

Foto des Verkäufers

Verlag: Springer (2013)
ISBN 10: 3642351603 ISBN 13: 9783642351600
Neu Hardcover Anzahl: 10
Anbieter:
booksXpress
(Bayonne, NJ, USA)
Bewertung

Buchbeschreibung Hardcover. Zustand: new. Bestandsnummer des Verkäufers 9783642351600

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 233,41
Währung umrechnen

In den Warenkorb

Versand: Gratis
Innerhalb der USA
Versandziele, Kosten & Dauer
Foto des Verkäufers

Friedli, Thomas|Basu, Prabir|Bellm, Daniel
ISBN 10: 3642351603 ISBN 13: 9783642351600
Neu Hardcover Anzahl: > 20
Print-on-Demand
Anbieter:
moluna
(Greven, Deutschland)
Bewertung

Buchbeschreibung Gebunden. Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Uses current data about the status and operations of pharmaceutical production Authors from big pharma contribute their own stories in the form of best practice case studies Theoretical backgrounds and practical insights are combined to off. Bestandsnummer des Verkäufers 5057867

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 201,17
Währung umrechnen

In den Warenkorb

Versand: EUR 48,99
Von Deutschland nach USA
Versandziele, Kosten & Dauer
Beispielbild für diese ISBN

Verlag: Springer (2013)
ISBN 10: 3642351603 ISBN 13: 9783642351600
Neu Hardcover Anzahl: > 20
Anbieter:
Lucky's Textbooks
(Dallas, TX, USA)
Bewertung

Buchbeschreibung Zustand: New. Bestandsnummer des Verkäufers ABLIING23Mar3113020224858

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 250,35
Währung umrechnen

In den Warenkorb

Versand: EUR 3,70
Innerhalb der USA
Versandziele, Kosten & Dauer
Beispielbild für diese ISBN

Thomas Friedli
Verlag: Springer (2013)
ISBN 10: 3642351603 ISBN 13: 9783642351600
Neu Hardcover Anzahl: > 20
Print-on-Demand
Anbieter:
Ria Christie Collections
(Uxbridge, Vereinigtes Königreich)
Bewertung

Buchbeschreibung Zustand: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Bestandsnummer des Verkäufers ria9783642351600_lsuk

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 251,17
Währung umrechnen

In den Warenkorb

Versand: EUR 11,63
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer
Beispielbild für diese ISBN

Friedli, Thomas
Verlag: Springer (2013)
ISBN 10: 3642351603 ISBN 13: 9783642351600
Neu Hardcover Anzahl: 1
Anbieter:
Wizard Books
(Long Beach, CA, USA)
Bewertung

Buchbeschreibung Hardcover. Zustand: new. New. Bestandsnummer des Verkäufers Wizard3642351603

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 264,29
Währung umrechnen

In den Warenkorb

Versand: EUR 3,25
Innerhalb der USA
Versandziele, Kosten & Dauer
Beispielbild für diese ISBN

Friedli, Thomas
Verlag: Springer (2013)
ISBN 10: 3642351603 ISBN 13: 9783642351600
Neu Hardcover Anzahl: 1
Anbieter:
Front Cover Books
(Denver, CO, USA)
Bewertung

Buchbeschreibung Zustand: new. Bestandsnummer des Verkäufers FrontCover3642351603

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 263,55
Währung umrechnen

In den Warenkorb

Versand: EUR 3,99
Innerhalb der USA
Versandziele, Kosten & Dauer
Foto des Verkäufers

Thomas Friedli
ISBN 10: 3642351603 ISBN 13: 9783642351600
Neu Hardcover Anzahl: 2
Print-on-Demand
Anbieter:
BuchWeltWeit Ludwig Meier e.K.
(Bergisch Gladbach, Deutschland)
Bewertung

Buchbeschreibung Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Achieving operational excellence is a challenge for the pharmaceutical industry, with many companies setting successful examples time and again. This book presents such leading practices for managing operational excellence throughout the pharmaceutical industry. Based on the St.Gallen OPEX Model the authors describe the current status of OPEX and the future challenges that have to be dealt with. The ample theoretical background is complemented hand-in-hand by case studies contributed by authors from leading pharmaceutical companies. 552 pp. Englisch. Bestandsnummer des Verkäufers 9783642351600

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 246,09
Währung umrechnen

In den Warenkorb

Versand: EUR 23,00
Von Deutschland nach USA
Versandziele, Kosten & Dauer
Foto des Verkäufers

Thomas Friedli
ISBN 10: 3642351603 ISBN 13: 9783642351600
Neu Hardcover Anzahl: 1
Anbieter:
AHA-BUCH GmbH
(Einbeck, Deutschland)
Bewertung

Buchbeschreibung Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Achieving operational excellence is a challenge for the pharmaceutical industry, with many companies setting successful examples time and again. This book presents such leading practices for managing operational excellence throughout the pharmaceutical industry. Based on the St.Gallen OPEX Model the authors describe the current status of OPEX and the future challenges that have to be dealt with. The ample theoretical background is complemented hand-in-hand by case studies contributed by authors from leading pharmaceutical companies. Bestandsnummer des Verkäufers 9783642351600

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 249,04
Währung umrechnen

In den Warenkorb

Versand: EUR 32,99
Von Deutschland nach USA
Versandziele, Kosten & Dauer
Beispielbild für diese ISBN

Friedli, Thomas
Verlag: Springer (2013)
ISBN 10: 3642351603 ISBN 13: 9783642351600
Neu Hardcover Anzahl: 1
Anbieter:
GoldBooks
(Denver, CO, USA)
Bewertung

Buchbeschreibung Hardcover. Zustand: new. New Copy. Customer Service Guaranteed. Bestandsnummer des Verkäufers think3642351603

Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren

Neu kaufen
EUR 330,60
Währung umrechnen

In den Warenkorb

Versand: EUR 3,95
Innerhalb der USA
Versandziele, Kosten & Dauer